Ketamine and suicidal ideation in depression: Jumping the gun?

作者: R. Rajkumar , J. Fam , E.Y.M. Yeo , G.S. Dawe

DOI: 10.1016/J.PHRS.2015.05.003

关键词:

摘要: Depression and suicide are known to be intricately entwined but the neurobiological basis underlying this association is yet understood. Ketamine an N-methyl d-aspartate (NMDA) receptor antagonist used for induction maintenance of general anaesthesia paradoxically its euphoric effects lead classification under drugs abuse. The serendipitous finding rapid-onset antidepressant action subanaesthetic dosing with ketamine by intravenous infusion has sparked many preclinical clinical investigations. A remarkable suppression suicidal ideation was also reported in depressed patients. This review focuses on trials that remedial depression addresses molecular mechanisms psychotomimetic actions ketamine. neuropsychiatric profile doses encourages use management could avert emergent self-harm or suicide. Finally, need neuroimaging studies patients identify brain region specific temporal ketamine, possibility employing as experimental tool rodent-based study behaviour highlighted.

参考文章(198)
Jie Chen, Xiu-Li Jiang, Bo-Xiang Du, Wei-Bin Shao, Jie Song, Lin Liu, MicroRNA-34a negatively regulates anesthesia-induced hippocampal apoptosis and memory impairment through FGFR1. International Journal of Clinical and Experimental Pathology. ,vol. 7, pp. 6760- 6767 ,(2014)
Hideo Matsumoto, Akiyoshi Nishiyama, Quetiapine reduces irritability and risk of suicide in patients with agitated depression. The Tokai journal of experimental and clinical medicine. ,vol. 38, pp. 93- 96 ,(2013)
Herbert Y. Meltzer, Suicide in schizophrenia: risk factors and clozapine treatment The Journal of Clinical Psychiatry. ,vol. 59, pp. 15- 20 ,(1998)
Vered Y, Weizman A, Gonen N, Mester R, Guy N, Roitman S, Graff E, Talmon Y, Spivak B, Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clinical Neuropharmacology. ,vol. 21, pp. 245- 250 ,(1998)
Rudolf Stohler, Michael Liebrenz, Alain Borgeat, Ria Leisinger, Intravenous ketamine therapy in a patient with a treatment-resistant major depression Swiss Medical Weekly. ,vol. 137, pp. 234- ,(2007) , 10.4414/SMW.2007.11852
Johannes Bjerre, Claus Fontenay, Ketamine in melancholic depression Ugeskrift for Læger. ,vol. 172, pp. 460- 461 ,(2010)
B. Karolewicz, K. Szebeni, C. A. Stockmeier, L. Konick, J. C. Overholser, G. Jurjus, B. L. Roth, G. A. Ordway, Low nNOS protein in the locus coeruleus in major depression Journal of Neurochemistry. ,vol. 91, pp. 1057- 1066 ,(2004) , 10.1111/J.1471-4159.2004.02792.X
James R. Gill, Marina Stajíc, Ketamine in Non-Hospital and Hospital Deaths in New York City Journal of Forensic Sciences. ,vol. 45, pp. 655- 658 ,(2000) , 10.1520/JFS14742J